CYTEK BIOSCIENCES INC. - COMMON STOCK
5.0600
04-10月-24 15:59:58
15 分の遅延
株式
-0.0800
-1.56%
本日の幅
5.0000 - 5.2700
ISIN
N/A
ソース
NASDAQ
-
Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
28 4 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
28 4 2022 08:00:04 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
23 2 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
16 2 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
11 2 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
05 1 2022 10:00:00 提供 Nasdaq GlobeNewswire
-
Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System
17 11 2021 10:00:00 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Third Quarter 2021 Financial Results
08 11 2021 16:05:02 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
03 11 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
26 10 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
07 10 2021 10:00:00 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
02 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Second Quarter 2021 Financial Results
02 9 2021 16:03:00 提供 Nasdaq GlobeNewswire